Cost Sharing Fight: PhRMA Says Insurance Design Is Real Pricing Culprit
Executive Summary
New report finds increase in use of deductibles and coinsurance charging members list prices.
You may also be interested in...
Under Pressure: Sanofi Joins Call For Price Transparency
As Sanofi joined the ranks of pharma companies pledging to limit annual US price increases, the company also released average aggregate list and net prices in 2016, showing net prices declined 2.1%.
US Branded Drug Invoice Price Increases Moderate In 2016
Price increases before rebates and other concessions stayed below double digits in 2016, as manufacturers responded to public and political pressure on pricing practices, the QuintilesIMS annual drug spending report shows.
US Branded Drug Invoice Price Increases Moderate In 2016
Price increases before rebates and other concessions stayed below double digits in 2016, as manufacturers responded to public and political pressure on pricing practices, the QuintilesIMS annual drug spending report shows.